Association between hepatitis B virus infection and HLA-DR type in Korea

Hepatology

Volumn 31, Issue 6, 2000, Pages 1371-1373

  Ahn, Sang Hoon ^a   Han, Kwang Hyub ^a,b   Park, Jeong Youp ^a   Lee, Chun Kyon ^a   Kang, Shin Wook ^a   Chon, Chae Yoon ^a   Kim, Yu Seun ^b   Park, Kiil ^b   Kim, Dong Kee ^b   Moon, Young Myoung ^a  

^a Department of Internal Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0034085348     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.7988     Document Type: Article

References (11)

1. Dudley FJ, Fox RA, Sherlock S. Cellular immunity and hepatitis associated antigen liver disease. Lancet 1972;742:1130-1142.
2. Chisari FV, Routenberg JA, Anderson DS. Cellular immunity reactivity in HBV-induced liver disease. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: The Franklin Institute Press, 1978:245-266.
3. Thomas HC, Montano L, Goodall A. Immunological mechanisms in chronic hepatitis B virus infection. HEPATOLOGY 1982;2:1165-1170.
4. Kaslow RA, Shaw S. The role of HLA in infection. Epidemiol Rev 1981;3:90-97.
5. Hattum JV, Geziena MT, Scheruder. HLA antigens in patients with various courses after hepatitis B infection. HEPATOLOGY 1987;7:11-14.
6. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between a MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-1069.
7. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Lohr HF, et al. HLA-DRB1*1301 and 1302 protect against chronic hepatitis B. J Hepatol 1997;26:503-507.
8. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998;113(2):244-251.
9. Beasley RP. Hepatitis B immunoglobulin efficacy in interruption of perinatal transmission of hepatitis B carrier state. Lancet 1981;2:388-397.
10. Thomas HC, Lerer A. Immunology for hepatologists. Prog Liver Dis 1985;8:179-187.
11. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994;344:1194-1195.